Cargando…
Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430396/ https://www.ncbi.nlm.nih.gov/pubmed/34513720 http://dx.doi.org/10.3389/fonc.2021.759471 |
_version_ | 1783750698973790208 |
---|---|
author | Yang, Wen Zheng, Zhikun Yi, Pengfei Wang, Shi Zhang, Ning Ming, Jie Tan, Jie Guo, Hui |
author_facet | Yang, Wen Zheng, Zhikun Yi, Pengfei Wang, Shi Zhang, Ning Ming, Jie Tan, Jie Guo, Hui |
author_sort | Yang, Wen |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8430396 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84303962021-09-11 Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling Yang, Wen Zheng, Zhikun Yi, Pengfei Wang, Shi Zhang, Ning Ming, Jie Tan, Jie Guo, Hui Front Oncol Oncology Frontiers Media S.A. 2021-08-27 /pmc/articles/PMC8430396/ /pubmed/34513720 http://dx.doi.org/10.3389/fonc.2021.759471 Text en Copyright © 2021 Yang, Zheng, Yi, Wang, Zhang, Ming, Tan and Guo https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Yang, Wen Zheng, Zhikun Yi, Pengfei Wang, Shi Zhang, Ning Ming, Jie Tan, Jie Guo, Hui Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling |
title | Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling |
title_full | Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling |
title_fullStr | Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling |
title_full_unstemmed | Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling |
title_short | Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling |
title_sort | corrigendum: lncrna nbr2 inhibits the malignancy of thyroid cancer, associated with enhancing the ampk signaling |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430396/ https://www.ncbi.nlm.nih.gov/pubmed/34513720 http://dx.doi.org/10.3389/fonc.2021.759471 |
work_keys_str_mv | AT yangwen corrigendumlncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling AT zhengzhikun corrigendumlncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling AT yipengfei corrigendumlncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling AT wangshi corrigendumlncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling AT zhangning corrigendumlncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling AT mingjie corrigendumlncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling AT tanjie corrigendumlncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling AT guohui corrigendumlncrnanbr2inhibitsthemalignancyofthyroidcancerassociatedwithenhancingtheampksignaling |